Correlation Between INVO Bioscience and Nuwellis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INVO Bioscience and Nuwellis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INVO Bioscience and Nuwellis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INVO Bioscience and Nuwellis, you can compare the effects of market volatilities on INVO Bioscience and Nuwellis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INVO Bioscience with a short position of Nuwellis. Check out your portfolio center. Please also check ongoing floating volatility patterns of INVO Bioscience and Nuwellis.

Diversification Opportunities for INVO Bioscience and Nuwellis

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between INVO and Nuwellis is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding INVO Bioscience and Nuwellis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuwellis and INVO Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INVO Bioscience are associated (or correlated) with Nuwellis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuwellis has no effect on the direction of INVO Bioscience i.e., INVO Bioscience and Nuwellis go up and down completely randomly.

Pair Corralation between INVO Bioscience and Nuwellis

Given the investment horizon of 90 days INVO Bioscience is expected to under-perform the Nuwellis. But the stock apears to be less risky and, when comparing its historical volatility, INVO Bioscience is 6.17 times less risky than Nuwellis. The stock trades about -0.1 of its potential returns per unit of risk. The Nuwellis is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  174.00  in Nuwellis on August 24, 2024 and sell it today you would lose (50.00) from holding Nuwellis or give up 28.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy69.57%
ValuesDaily Returns

INVO Bioscience  vs.  Nuwellis

 Performance 
       Timeline  
INVO Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days INVO Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak basic indicators, INVO Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point.
Nuwellis 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nuwellis are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Nuwellis exhibited solid returns over the last few months and may actually be approaching a breakup point.

INVO Bioscience and Nuwellis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INVO Bioscience and Nuwellis

The main advantage of trading using opposite INVO Bioscience and Nuwellis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INVO Bioscience position performs unexpectedly, Nuwellis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuwellis will offset losses from the drop in Nuwellis' long position.
The idea behind INVO Bioscience and Nuwellis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.